In contrast, in hepatocellular carcinoma (HCC), low NPC1L1 expression correlates with a higher incidence of poorly differentiated tumors, vascular invasion, and an increased number of patients with advanced pathological stages [17]. Here, NPC1L1 is linked to hepatocellular carcinoma.